GUNA-IL 12- interleukin-12 human recombinant solution/ drops संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

guna-il 12- interleukin-12 human recombinant solution/ drops

guna spa - interleukin-12 human recombinant (unii: 02fxp10o2u) (interleukin-12 human recombinant - unii:02fxp10o2u) - interleukin-12 human recombinant 4 [hp_c] in 30 ml - interleukin-12   4c   anti-allergy immune support anti-allergy immune support take 15 minutes before meals.

Vepured Formulation: Each I mL (dose) of vaccine contains: Recombinant Verotoxin 2e RP 21.50 * Suspension for Injection (IM) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

vepured formulation: each i ml (dose) of vaccine contains: recombinant verotoxin 2e rp 21.50 * suspension for injection (im)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated recombinant escherichia coli verotoxin vaccine (vet.) - suspension for injection (im) - formulation: each i ml (dose) of vaccine contains: recombinant verotoxin 2e rp 21.50 *

Recombitek C4/CV Each dose 1.0 mL of vaccine contains the following through expiration: Active Ingredients: Canarypox/ Canine distemper virus recombinant, CP258, Rentschler/Onderstepoort strain, at least ................................................................................... >106.4TCID50 Canine adenovirus type 2, Toronto A/26/61 strain, at least ...................... >104.3 TCID50 Canine parvovirus, 780916 strain, at least ............................................. >103.3 FAID50 Canine parainfluenza virus, D-008 strain, at least ................................... >103.9 TCID50 Canine coronavirus, K-378/51 strain, at least........................................... >103.6 TCID50 "TCID-Tissue Culture Infective Dose "FAID- Fluorescent Antibody Infective Dess Lyophilized Powder for Injection (IM/SC) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

recombitek c4/cv each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus vaccine (ccv) (vet.) - lyophilized powder for injection (im/sc) - each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess

Recombitek C8 Formulation: Each mL of reconstituted vaccine (dose) contains: Canine distemper virus recombinant CP258 (Onderstepoort Strain).............> 10^6.4 TCID50 Canine adenovirus type 2 (Toronto A/26/61 Strain)...............> 10^4.3 TCID50 Canine parvovirus (780916 Strain).................> 10^3.3 FAID50 Canine parainfluenza virus (D-008 Strain).................> 10^3.9 TCID50 Leptospira interrogans ser. Canicola (1503 P4 Strain)..................> 200 FTU Leptospira interrogans ser. Icterohaemorrhagiae (ST1518 Strain)..................> 200 FTU Leptospira interrogans ser. Grippotyphosa (SC4397 Strain)..................> 300 FTU Leptospira interrogans ser. Pomona (T262 Strain)..................> 300 FTU TCID-Tissue Culture Infective Dose FAID. Fluorescent Antibody Indoctive Dese FTU-Formazin Turbidity Units Lyophilized Powder for Injection (IM/SC) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

recombitek c8 formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , l. interrogans ser. icterohaemorrhagiae , l. interrogans ser. grippotyphosa , l. interrogans ser. pomona vaccine (vet.) - lyophilized powder for injection (im/sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units

Innovax-ILT Formulation: Each dose contains: Recombinant Marek's Disease Virus (HVT FC-126 Strain......... > 2248 PFU Infectious Laryngotracheitis Virus (D and I Glycoprotein, 138 Strain) PFU - Plaque Forming Unit Suspension for Injection (In-Ovo/SC) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

innovax-ilt formulation: each dose contains: recombinant marek's disease virus (hvt fc-126 strain......... > 2248 pfu infectious laryngotracheitis virus (d and i glycoprotein, 138 strain) pfu - plaque forming unit suspension for injection (in-ovo/sc)

msd animal health (phils.), inc.; distributor: n.a. - live recombinant marek's disease (md) virus , infectious laryngotracheitis (ilt) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: recombinant marek's disease virus (hvt fc-126 strain......... > 2248 pfu infectious laryngotracheitis virus (d and i glycoprotein, 138 strain) pfu - plaque forming unit

Purevax Felv 1 dose of 1mL or 0.5 mL contains FeLV recombinant Canarypoxvirus (vCP97-10˄7.2CCID50 Suspension For Injection (Sc) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

purevax felv 1 dose of 1ml or 0.5 ml contains felv recombinant canarypoxvirus (vcp97-10˄7.2ccid50 suspension for injection (sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - feline leukemia of felv recombinant canarypox virus vaccine (vcp97) - suspension for injection (sc) - 1 dose of 1ml or 0.5 ml contains felv recombinant canarypoxvirus (vcp97-10˄7.2ccid50

Vaxxitek HVT + IBD + ND Formulation: Each dose contains: Marek's Disease Virus, Serotype 3, VHVT310 (Recombinant HVT, FC-126 Strain) ............... >5696 pfu Infectious Bursal Disease Viral Protein 2 Newcastle Disease Virus Fusion (F) Protein, Genotype VIID PFU - Plaque Forming Unit Suspension for Injection (In-Ovo/SC) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

vaxxitek hvt + ibd + nd formulation: each dose contains: marek's disease virus, serotype 3, vhvt310 (recombinant hvt, fc-126 strain) ............... >5696 pfu infectious bursal disease viral protein 2 newcastle disease virus fusion (f) protein, genotype viid pfu - plaque forming unit suspension for injection (in-ovo/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live recombinant marek's disease (md) virus , infectious bursal disease (ibd) virus , newcastle disease (nd) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: marek's disease virus, serotype 3, vhvt310 (recombinant hvt, fc-126 strain) ............... >5696 pfu infectious bursal disease viral protein 2 newcastle disease virus fusion (f) protein, genotype viid pfu - plaque forming unit

SHINGRIX Recombinant Varicella Zoster Virus glycoprotein E antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

shingrix recombinant varicella zoster virus glycoprotein e antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection

glaxosmithkline australia pty ltd - recombinant varicella zoster virus glycoprotein e antigen, quantity: 50 microgram - injection, powder for - excipient ingredients: sucrose; monobasic sodium phosphate dihydrate; dibasic potassium phosphate; polysorbate 80 - shingrix is indicated for the prevention of herpes zoster (hz) and post-herpetic neuralgia in: - adults 50 years of age or older; - adults 18 years of age or older at increased risk of hz.

ZARZIO SOLUTION FOR INJECTIONINFUSION IN A PREFILLED SYRINGE 30MU0.5ML सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

zarzio solution for injectioninfusion in a prefilled syringe 30mu0.5ml

sandoz singapore pte. ltd. - recombinant filgrastim - injection, solution - recombinant filgrastim 0.30mg/0.5ml

PULMOZYME इसराइल - अंग्रेज़ी - Ministry of Health

pulmozyme

roche pharmaceuticals (israel) ltd - recombinant human deoxyribonuclease - solution for inhalation - recombinant human deoxyribonuclease 1 mg/ml - dornase alfa (desoxyribonuclease) - dornase alfa (desoxyribonuclease) - management of cystic fibrosis not for patients under 5 years of age or with fvc<40% .